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ABSTRACT
CHIK is an arboviral infection caused by chikungunya virus transmitted by Aedes mosquito worldwide. It usually 
manifests as a self-limiting acute febrile illness with rash, body ache and severe polyarthralgia; in some patients, 
symptoms persist up to months or even years. Neurological manifestations are relatively uncommon. In recent years 
Pakistan and other South East Asian countries have been hit several times by its epidemics1. We report a case of a 
middle-aged male who presented in our hospital with acute febrile illness along with neurological manifestations. 
Extensive laboratory investigations were done and he was diagnosed with seropositive CHIKV. He was treated 
symptomatically and recovered without any complication. Although previously cases of chikungunya 
meningoencephalitis have been reported in Pakistan during epidemics; such cases sporadically have not been reported 
so far1.
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C A S E  R E P O R T
CASE PRESENTATION: CHIV usually manifests as a 
self-limiting acute febrile illness with rash, body ache 
and severe polyarthralgia; transmitted by Aedes species 
of mosquito. Neurological manifestations are relatively 
uncommon. In November 2017, a 48-year-old man 
from Karachi presented to our hospital with a 10-day 
history of fever, headache, arthralgia and altered 
mental status. He had no recent travel history. His 
exposure history was notable for recent mosquito bites. 
On general physical exam, there was no rash. He was 
drowsy, responding on verbal stimulus but did not follow 
commands. His neck was stiff. Cranial nerves were 
intact. Fundus examination was normal. There was no 
focal deficit on motor neurological examination. He had 
two episodes of witnessed tonic clonic seizures of brief 
duration during hospital stay and was managed on 
intravenous Levetiracetam. On admission his routine 
baseline investigations were sent. His hemoglobin level 
was 12.9 g/dl, platelet count 166,000/l, white blood 
cell (WBC) count was 3,900/l with 59.6% neutrophils, 
27.7% lymphocytes, 10.1% monocytes and 2% 
eosinophils. Creatinine level was 0.8 mg/dl, and liver 
function tests were within normal limits. Urinalysis 
showed no evidence of infection; urine toxicology 
screen was negative. Lumbar puncture revealed an 
opening pressure of 18 cm of water, 5 WBC/l, 0 red 
blood cells/l, glucose of 84 mg/dl (serum glucose=140 
mg/dl), and protein level of 47 mg/dl See Table 1). He 
was admitted in the neurology ward. CT and MRI of the 
Brain with contrast were unremarkable. 
Electroencephalography (EEG) showed diffuse slowing. 
No epileptiform discharges were seen. Bacterial 
cultures from blood and CSF were negative. The 
following infectious disease testing was performed and 
was negative: dengue serology; and CSF PCRs for E. 
Coli, Hemophilus influenza, Listeria, Neisseria 
meningitides, Streptococcus, Enterovirus, Herpes 
simplex virus, Human parvo virus, Varicella-zoster virus, 
Cytomegalovirus and Cryptococcus. Although there was 
no epidemic of CHIK in region; serological specimens 
were sent to laboratory for CHIKV, dengue, Plasmodium 
falciparum and other Plasmodium species as well. 
Malaria and Dengue were negative however on day two 
of presentation serum anti-CHIKV IgM was found to be 
positive. His symptoms improved with supportive 
treatment of intravenous fluid replacement and 
antiepileptic medications along with antipyretics. No 
specific antiviral medications were given. A week after 
admission in hospital, patient was discharged in stable 
condition. He continued follow up for six months and no 
complications were noted.
DISCUSSION:
A wide spectrum of neurological manifestations 
including meningoencephalitis, myelopathy and 
neuropathy have been reported following CHIKV 
infection (see table2)1,2,3. In one retrospective study4, 
147 (4.1%) patients with neurological manifestations 
out of 610 patients with chikungunya infection were 
reported with presentation of encephalitis (11%), 
meningoencephalitis (2%), epileptic seizures (2%), 
Guillain-Barre syndrome (1%), cerebellar syndrome (< 
1%) stroke (< 1%), and myelomeningoencephalitis (< 
1%). In one case series5, altered behavior or altered 
mental status was most common (95%); other features 
such as headache (30%), seizures (26%) and motor 
dysfunction (4%) were also noted. Cerebrospinal fluid 
(CSF) findings were chiefly elevated CSF protein levels, 
normal glucose levels and pleocytosis. The diagnosis of 
chikungunya infection was serologically confirmed by 
finding either CHIKV specific IgM or RT-PCR in these 
patients. As in our case, patient had fever, headache, 
arthralgia, altered mental status and seizures and EEG 
changes were non-specific mostly slow waves as 
described in previously described case series along with 
unremarkable neuroimaging.
Overall, CHIKV infection can result in a wide variety of 
neurological conditions (Table 2), occurring in up to one 
third of patients. Encephalitis appears to be the most 
common neurological manifestation, its incidence 
ranging from 11 to 18%4,5. Certainly, difficulties may 
arise in determining whether CHIK infection is the 
definite cause of the neurological manifestations, 
especially during non-epidemic seasons and in areas 
where the prevalence of the disease is low. In many of 
the studies as noted in literature, the reported degree 
to which investigations were performed to exclude other 
infections was variable4-9. It is however important to 
remember that cases with neurological manifestations 
can occur without any epidemic. Diagnosis is mainly 
clinical, along with laboratory confirmation of recent 
CHIKV infection (Table 1). EEG appears unhelpful in 
diagnosis. CSF findings appear to be similar to those 
seen in other viral encephalitis/meningitis: elevated 
proteins, normal glucose and pleocytosis6,7. However, 
all these cases presented in epidemics and our case is 
significant to report as it presented in the non-epidemic 
season with a serious neurological manifestation. Case 
series of patients in non-epidemic season are currently 
not available in literature to the best of our knowledge.
CONCLUSION:
To our knowledge, previously no cases of chikungunya 
encephalitis have been reported in absence of an 
ongoing epidemic in Pakistan. Therefore, it is important 
to consider chikungunya infection as the cause of 
symptoms in patients presenting with neurological 
manifestations together with features of febrile illness, 
sporadically in the off season as noted in our patient.
Table 1. List of baseline laboratory investigations
Table 2. List of neurological manifestations 
associated with Chikungunya virus
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